3rd Annual Global Drug Bioavailability Enhancement Summit: 2-Day Event (Philadelphia, PA, United States - June 26-27, 2019) - ResearchAndMarkets.com
The "3rd Annual Global Drug Bioavailability Enhancement Summit" conference has been added to ResearchAndMarkets.com's offering.
Back by popular demand, the 3rd Annual Global Drug Bioavailability Enhancement Summit will be providing a holistic overview to bioavailability enhancements.
The organizer will be covering everything from large molecules to small molecules; oral drugs and parenterals (including nasal, pulmonary, transdermal, microneedles, ocular and more); as well as will be bridging the gap from early to late stage discovery and development.
Throughout the program, the organizer will be bringing real-world stories and case-studies and covering the sessions and topics with best practices and lessons learned in interesting and interactive sessions, panels and roundtables instead of the standard, mundane traditional-style presentations.
In addition, the 3rd Annual Global Drug Bioavailability Enhancement Summit strives to provide you unique and interesting solutions that can assist you and others on your team.
The organizer knows that prediction and modeling tools and technologies; the move to continuous manufacturing; manners and methods to utilizing data; and legal, regulatory solutions amongst others are important to your role and company - and, the goal is to make sure the organizer can provide you a wide array of ideas, tools, technologies, perspectives and thoughts to make your job easier.
This event will truly provide to you and your colleagues great ideas and perspectives to share and further improve your strategies to bring novel formulations to-market more quickly.
New for 2019: This event is co-located with the 3rd Annual Oral Drug Formulation Innovations Summit. Attendees and sponsors have access to this event as a value add.
For more information about this conference visit https://www.researchandmarkets.com/research/8bw74v/3rd_annual_global?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181213005792/en/